About Anaxlaboratories Private Limited
Data last updated: 05 January 2026
Anaxlaboratories Private Limited is a private limited company based in Siddipet, Telangana, India. It specialises in pharma contract r and d, a part of the broader pharmaceuticals sector. Incorporated on 20 October 2016, the company has been in operation for over 10 years.
Registered with ROC Hyderabad under CIN U33110TG2016PTC112562.
Capital: an authorised share capital of ₹1.36 Cr and a paid-up capital of ₹1.36 Cr. It is led by directors including Karnati Kiran Kumar and Mastan Dudekula.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Plot No.36/A Biotech Park Phase – 3, Siddipet, Telangana, India – 502279.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.38 Cr, a growth of 92% compared to the previous year.
The company is associated with 1 brand - Anax Laboratories. As per MCA filings, the company has open charges of ₹2.26 Cr and satisfied charges of ₹2.26 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website anaxlab.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered AddressPlot No.36/A Biotech Park Phase – 3, Siddipet, Telangana, India – 502279
-
IndustryPharma, Pharma Contract R&D
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Anaxlaboratories Private Limited
Anaxlaboratories Private Limited operates one associated brand: Anax Laboratories. These brands represent Anaxlaboratories Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Offers chemistry solutions for drug discovery and manufacturing services. | anaxlab.com |
Competitors & Alternatives of Anaxlaboratories Private Limited
Brands and companies operating in the same space as Anaxlaboratories Private Limited include Inventys, Viyash, Blue Jet Healthcare and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
|
|
Actives, advanced intermediates, and specialty chemicals are custom manufactured. | Mumbai, India, India | 2005 |
|
|
APIs and intermediates are manufactured by Viyash as a CDMO. | Hyderabad, India, India | 2019 |
|
|
CDMO focused on manufacturing, supplier, and development of intermediates & APIs | Mumbai, India, India | 1969 |
|
|
Advanced API intermediates are manufactured for pharmaceutical use. | Surat, India, India | 2007 |
|
|
API intermediates are manufactured by Aparna Pharmaceuticals as a CDMO. | Hyderabad, India, India | 2008 |
|
|
APIs, intermediates, and finished dosage forms are manufactured. | Hangzhou, China, China | 2004 |
|
|
CDMO focused on manufacturing of APIs and intermediates | Berlin, Germany, Germany | 2019 |
|
|
Enanti Labs produces pharmaceutical intermediates and APIs in India with quality focus. | Hyderabad, India, India | 2007 |
|
|
Manufactures and exports pharmaceutical intermediates for global markets. | Hyderabad, India, India | 2007 |
Business Activity of Anaxlaboratories Private Limited
Anaxlaboratories Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Anaxlaboratories Private Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Anaxlaboratories Private Limited
Anaxlaboratories Private Limited is audited by K A B AND ASSOCIATES for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| K A B AND ASSOCIATES | Locked | Locked | Locked |
Complete auditor history for Anaxlaboratories Private Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Anaxlaboratories Private Limited
Anaxlaboratories Private Limited is currently managed by 3 directors, with 3 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Karnati Kiran Kumar
Also directs:
Abokh Chemicals Private Limited
|
Director | 20 Oct 2016 | 9 Years 8 Months | Current |
|
Mastan Dudekula
Also directs:
Abokh Chemicals Private Limited
|
Director | 20 Oct 2016 | 9 Years 8 Months | Current |
|
Revanuri Sudha Devi
Also directs:
Abokh Chemicals Private Limited
|
Director | 20 Oct 2016 | 9 Years 8 Months | Current |
Financials of Anaxlaboratories Private Limited FY 2025 filings available
Anaxlaboratories Private Limited reported revenue of ₹4.38 Cr (up 92.00% YoY) for FY 2025.
Ten-year financial statements for Anaxlaboratories Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Anaxlaboratories Private Limited
Shareholding and ownership data for Anaxlaboratories Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Anaxlaboratories Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Mar 2023 | Others | ₹50 Lakh | Satisfied |
| 14 Sep 2020 | Others | ₹1.76 Cr | Satisfied |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Anaxlaboratories Private Limited
View historical data on people associated with Anaxlaboratories Private Limited, including employment history and EPFO contributions.
Employee and EPFO history for Anaxlaboratories Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Anaxlaboratories Private Limited
GST registrations and filing compliance for Anaxlaboratories Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Anaxlaboratories Private Limited
Credit ratings, litigation, and regulatory alerts for Anaxlaboratories Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Anaxlaboratories Private Limited
MSME payment history for Anaxlaboratories Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Anaxlaboratories Private Limited
Corporate group structure for Anaxlaboratories Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Anaxlaboratories Private Limited
MCA filings and documents for Anaxlaboratories Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Anaxlaboratories Private Limited
Frequently Asked Questions about Anaxlaboratories Private Limited
Anaxlaboratories Private Limited is an active private limited company in the pharma sector based in Siddipet, Telangana, India. It was incorporated on 20 October 2016 (10+ years old) and is registered under CIN U33110TG2016PTC112562.
Anaxlaboratories Private Limited reported revenue of ₹4.38 Cr for FY 2025 (up 92.00% YoY).
The current directors of Anaxlaboratories Private Limited are:
- Karnati Kiran Kumar - Director
- Mastan Dudekula - Director
- Revanuri Sudha Devi - Director
The primary industry of Anaxlaboratories Private Limited is pharma. The company specifically operates in pharma contract r and d. The company is currently active in this sector.
Anaxlaboratories Private Limited can be reached at the registered office: Plot No.36A Biotech Park Phase – 3, Siddipet, Telangana, India – 502279, or through the website anaxlab.com.
The authorised capital is ₹1.36 Cr, and the paid-up capital is ₹1.36 Cr.